The partnership extends the compatibility of Sequel’s Twiist system to allow people with Type 1 diabetes to pair the device ...

Sequel Med Tech and Senseonics today announced a commercial development agreement to combine insulin delivery and glucose ...

Sequel’s twiist will become the first automated insulin delivery system to integrate with Senseonics' one-year CGM system.

Senseonics and newcomer pump developer Sequel Med Tech have a plan to connect their diabetes technologies, with the goal of ...

Abbott announced today that it entered a first-of-its-kind agreement to integrate data from its Libre systems into Epic EHR ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

Global sensation Nick Jonas has always been open about his health journey, and recently, the singer reflected on being ...

According to Yogish C. Kudva, Division of Endocrinology, Diabetes, Nutrition, Mayo Clinic, Rochester, Minnesota, USA, and ...

The highs and lows of blood glucose aren't just an energy rollercoaster; they could be a key to detecting diabetes risk early ...

Abbott (NYSE: ABT), the global leader in continuous glucose monitoring (CGM) biowearable technology1, today announced that it has entered a first-of-its-kind agreement to integrate data from its world ...

Discover how Samsung Galaxy Watch 8 non-invasive glucose monitoring is revolutionizing diabetes care and wearable health ...

Trends indicate increasing adoption among adults aged 20+, with significant expansion in the male CGM market. Key players include Dexcom, Inc., Abbott Laboratories, and Medtronic. The report offers ...